Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lopinavir/Ritonavir in PLWH With High-Grade AIN
Sponsor: University of Wisconsin, Madison
Summary
This study is being done to assess the safety of lopinavir/ritonavir in patients with PLWH with AIN. 30 participants will be recruited and can expect to be on active study for approximately 3 months and long term follow up for 40 weeks.
Official title: A Phase I Study of Intra-anally Administered Lopinavir/Ritonavir in People Living With HIV (PLWH) With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
21
Start Date
2023-12-19
Completion Date
2026-06
Last Updated
2026-02-10
Healthy Volunteers
No
Interventions
Lopinavir / Ritonavir
Human Immunodeficiency Virus (HIV) antiviral, given via suppository
Locations (1)
UW Digestive Health Center Anoscopy Clinic
Madison, Wisconsin, United States